NCT00534079 Nasal Inhalation of Pulmozyme in Patients With Cystic Fibrosis and Chronic Rhinosinusitis Status COMPLETED Phase PHASE3
NCT00531882 Pilot Mouthwash Study of Pioglitazone and Simvastatin in Healthy Volunteers Status COMPLETED Phase NA
NCT00531531 Evaluation of the Emission Distance of P. Aeruginosa From the Respiratory Tract of People With Cystic Fibrosis Status COMPLETED Phase N/A
NCT00530244 Use of Formula Fortified With DHA in Infants With Cystic Fibrosis Status COMPLETED Phase NA
NCT00528190 Treatment of Aspergillus Fumigatus (a Fungal Infection) in Patients With Cystic Fibrosis Status COMPLETED Phase PHASE4
NCT00515229 Anti-Inflammatory Pulmonal Therapy of CF-Patients With Amitriptyline and Placebo Status COMPLETED Phase PHASE2
NCT00513682 Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI) Status COMPLETED Phase PHASE3
NCT00510484 Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis Status COMPLETED Phase PHASE3
NCT00506792 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QAU145 in Patients With Cystic Fibrosis Status COMPLETED Phase PHASE2
NCT00506688 Efficacy and Safety Study of Inhaled Glutathione in Cystic Fibrosis Patients Status COMPLETED Phase PHASE2
NCT00504361 Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar) Status COMPLETED Phase N/A
NCT00503490 Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis Status COMPLETED Phase PHASE1
NCT00499837 Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients Status COMPLETED Phase PHASE2
NCT00499720 Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection Status APPROVED_FOR_MARKETING Phase N/A
NCT00486837 Deposition of Inhaled Prolastin in Cystic Fibrosis Patients Status COMPLETED Phase PHASE2
NCT00483769 One Year Glargine Treatment in CFRD Children and Adolescents Status COMPLETED Phase PHASE4
NCT00476281 Nutritional, Metabolic and Respiratory Status in Cystic Fibrosis Status COMPLETED Phase NA